TA Pharma Incorporation is a forward-thinking pharmaceutical wholesale distributor cum exporter specializing in high-quality anticancer medications. Committed to safety, efficacy, and innovation, we aim to improve global healthcare by providing cutting-edge supply that make a meaningful impact in the fight against cancer

+ (91) 701-943-9759
export@tapharmainc.com

Related Posts


Welcome to TA Pharma Incorporation, where innovation, quality, and care converge to bring life-changing pharmaceutical solutions to the world.
Title Image

Our Products

Home  /  Our Products  /  Oncology  /  Dasatinib Tablets 50 mg

Dasatinib Tablets 50 mg

Dasatinib Tablets 50 mg is a medication used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), especially in patients who have specific genetic mutations such as Philadelphia chromosome-positive (Ph+). Dasatinib is a tyrosine kinase inhibitor that works by blocking the activity of BCR-ABL, an abnormal protein that promotes the growth of cancer cells. By inhibiting this protein, Dasatinib helps to slow or stop the growth of leukemia cells.

The 50 mg dosage is typically taken once or twice daily, depending on the condition being treated and the patient’s response. Common side effects may include fatigue, headache, nausea, fluid retention, and low blood cell counts. Regular monitoring of blood counts and liver function is important to detect any potential side effects or complications.

SKU: 00015 Category: Tag:

Description

Dasatinib Tablets 50 mg is a medication used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), especially in patients who have specific genetic mutations such as Philadelphia chromosome-positive (Ph+). Dasatinib is a tyrosine kinase inhibitor that works by blocking the activity of BCR-ABL, an abnormal protein that promotes the growth of cancer cells. By inhibiting this protein, Dasatinib helps to slow or stop the growth of leukemia cells.

The 50 mg dosage is typically taken once or twice daily, depending on the condition being treated and the patient’s response. Common side effects may include fatigue, headache, nausea, fluid retention, and low blood cell counts. Regular monitoring of blood counts and liver function is important to detect any potential side effects or complications.